Showing results (1-10 of 88) with videos related to
Sort By:
Pageof 9
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 9, 2017
Treatment algorithms for multiple myeloma in JapanShuji Ozaki[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 12, 2018
[Treatment strategy for relapsed or refractory myeloma according to the new Guidelines]Shuji OzakiNihon Rinsho. Japanese Journal of Clinical Medicine|December 12, 2007
[Imaging techniques in multiple myeloma]Shuji OzakiBiomed Research International|April 11, 2014
Autologous stem cell transplantation in elderly patients with multiple myeloma: past, present, and futureShuji Ozaki, Kazuyuki ShimizuBiomed Research International|August 22, 2014
Targeted therapy for HM1.24 (CD317) on multiple myeloma cellsTakeshi Harada, Shuji Ozaki[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 16, 2018
[Azacitidine treatment for acute myeloid leukemia with myelodysplasia-related changes during peritoneal dialysis]Takashi Omatsu, Kengo Udaka, Hironobu Shibata, et al.Journal of Bone and Mineral Metabolism|December 6, 2008
Vicious cycle between myeloma cell binding to bone marrow stromal cells via VLA-4-VCAM-1 adhesion and macrophage inflammatory protein-1alpha and MIP-1beta productionMasahiro Abe, Kenji Hiura, Shuji Ozaki, et al.International Journal of Hematology|March 10, 2004
Primary adult T-cell leukemia/lymphoma of boneTomoko Hara, Shingo Wakatsuki, Shuji Ozaki, et al.Plos One|April 6, 2023
Treatment pattern and clinical outcomes in multiple myeloma patients in Japan using the Medical Data Vision claims databaseHiroshi Handa, Tadao Ishida, Shuji Ozaki, et al.[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 24, 2014
[Rapidly progressive AL amyloidosis in a patient with relapsed multiple myeloma after achieving a complete response to tandem autologous PBSCT]Hikaru Yagi, Shuji Ozaki, Etsuko Sekimoto, et al.Pageof 9